Phase III Study of adjuvant chemotherapy for the patients resected pathological stage I(T1>2cm) Non Small Cell Lung Cancer (JCOG0707).
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Tegafur/uracil (Primary)
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 06 Mar 2014 Planned End Date changed from 1 Nov 2016 to 10 Nov 2018 as reported by University Hospital Medical Information Network - Japan record.
- 17 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported in University Hospital Medical Information Network - Japan record.